Language Selector

    Innovative Medicines Initiative 2

    Joint Technology Initiative - IMI2

    The Innovative Medicines Initiative (IMI) is Europe's largest public-private initiative aiming to speed up the development of better and safer medicines for patients.

    IMI supports collaborative research projects and builds networks of industrial and academic experts in order to boost pharmaceutical innovation in Europe.

    IMI is a joint undertaking between the European Union and the pharmaceutical industry association EFPIA.

    More information and support

    Your IMI2 Contacts

    Sasha Hugentobler, NCP Health
    Tel.: +41 31 380 60 06

    Nicole Wyss, NCP Health
    Tel.: +41 31 380 60 04
    Belpstrasse 11
    3007 Bern